SCHEMBL17882235

SCHEMBL17882235

CCC[C@H](C)OC(=O)CCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H](C(C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)C(C)O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 3/20 0.81
▸ RCOR1 Q9UKL0 2/20 0.81
▸ TERF2IP Q9NYB0 2/20 0.40
▸ LDHB P07195 1/20 0.39
▸ EGFR P00533 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ PSMB5 P28074 3/20 0.38
▸ PSMB2 P49721 2/20 0.38
▸ SSTR2 P30874 4/20 0.38
▸ SSTR4 P31391 3/20 0.38
▸ SSTR5 P35346 3/20 0.38
▸ SSTR1 P30872 2/20 0.38
▸ SSTR3 P32745 2/20 0.38
▸ TERF2 Q15554 2/20 0.37
▸ TEAD4 Q15561 1/20 0.37
▸ TEAD3 Q99594 1/20 0.37
▸ F11 P03951 1/20 0.37
▸ NPY1R P25929 1/20 0.37
▸ NPY2R P49146 1/20 0.37
▸ NPY4R P50391 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19386975 1.00 KDM1A (0.81) KDM1ARCOR1TERF2IPLDHBEGFR
SCHEMBL17882148 1.00 KDM1A (0.81) KDM1ARCOR1TERF2IPLDHBEGFR
SCHEMBL19386868 1.00 KDM1A (0.81) KDM1ARCOR1TERF2IPLDHBEGFR
SCHEMBL19386986 1.00 KDM1A (0.81) KDM1ARCOR1TERF2IPLDHBEGFR
SCHEMBL19386977 0.97 KDM1A (0.81) KDM1ARCOR1TERF2IPLDHBEGFR
SCHEMBL19386984 0.97 KDM1A (0.81) KDM1ARCOR1TERF2IPLDHBEGFR
SCHEMBL17882145 0.96 KDM1A (0.81) KDM1ARCOR1TERF2IPLDHBEGFR
SCHEMBL17860734 0.94 KDM1A (0.78) KDM1ARCOR1TERF2IPLDHBTERF2
SCHEMBL19386849 0.94 KDM1A (0.78) KDM1ARCOR1TERF2IPLDHBTERF2
SCHEMBL19386873 0.94 KDM1A (0.72) KDM1ARCOR1TERF2IPLDHBEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9771394-B2 Antimicrobial polymyxins for treatment of bacterial infections MICURX PHARMACEUTICALS, INC. (KY) 2017-09-26 — — US disclosed
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS MICURX PHARMACEUTICALS, INC. 2016-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS VIP, AQP1, PEF1 KDM1A 4119/4885RCOR1 4858/4885TERF2IP 4476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback